Granite Islands Private Wealth LLC Makes New $3.79 Million Investment in Danaher Corporation $DHR

Granite Islands Private Wealth LLC purchased a new stake in shares of Danaher Corporation (NYSE:DHR) in the 3rd quarter, Holdings Channel reports. The institutional investor purchased 17,110 shares of the conglomerate’s stock, valued at approximately $3,791,000. Danaher makes up 2.2% of Granite Islands Private Wealth LLC’s investment portfolio, making the stock its 12th biggest holding.

Other institutional investors have also added to or reduced their stakes in the company. EP Wealth Advisors LLC purchased a new position in Danaher during the 2nd quarter valued at about $3,807,000. Puzo Michael J purchased a new stake in Danaher in the 2nd quarter worth approximately $8,624,000. Madison Asset Management LLC bought a new stake in shares of Danaher in the 2nd quarter worth approximately $85,451,000. First Nebraska Trust Co bought a new stake in shares of Danaher in the 2nd quarter worth approximately $14,106,000. Finally, Colton Groome Financial Advisors LLC bought a new stake in shares of Danaher in the 3rd quarter worth approximately $592,000. Hedge funds and other institutional investors own 79.05% of the company’s stock.

Danaher Price Performance

DHR stock opened at $231.52 on Friday. The company has a debt-to-equity ratio of 0.48, a current ratio of 1.65 and a quick ratio of 1.25. Danaher Corporation has a 1 year low of $160.93 and a 1 year high of $242.80. The firm has a 50-day moving average of $213.55 and a 200 day moving average of $195.74. The company has a market cap of $162.76 billion, a P/E ratio of 41.12, a PEG ratio of 2.82 and a beta of 0.76.

Danaher (NYSE:DHR) last posted its quarterly earnings data on Monday, July 20th. The conglomerate reported $1.94 earnings per share for the quarter, beating the consensus estimate of $1.85 by $0.09. Danaher had a return on equity of 11.04% and a net margin of 15.95%. The business had revenue of $6.26 billion for the quarter, compared to analysts’ expectations of $6.12 billion. During the same period in the previous year, the firm posted $0.77 EPS. The business’s revenue was up 5.5% on a year-over-year basis. On average, sell-side analysts forecast that Danaher Corporation will post 8.53 EPS for the current year.

Danaher Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Friday, October 30th. Investors of record on Wednesday, September 30th will be paid a $0.40 dividend. This represents a $1.60 annualized dividend and a yield of 0.7%. The ex-dividend date of this dividend is Wednesday, September 30th. Danaher’s dividend payout ratio is presently 28.42%.

Analyst Ratings Changes

Several research firms have recently issued reports on DHR. Guggenheim boosted their target price on Danaher from $200.00 to $250.00 and gave the company a “buy” rating in a research note on Thursday, October 1st. The Goldman Sachs Group raised their price target on Danaher from $210.00 to $250.00 and gave the stock a “buy” rating in a research note on Monday, September 21st. Weiss Ratings upgraded shares of Danaher from a “hold (c-)” rating to a “hold (c)” rating in a report on Wednesday, September 16th. Wells Fargo & Company reduced their price objective on shares of Danaher from $212.00 to $195.00 and set an “equal weight” rating on the stock in a research report on Wednesday, July 22nd. Finally, Evercore reissued an “outperform” rating and set a $230.00 price objective on shares of Danaher in a research report on Monday, July 6th. Two research analysts have rated the stock with a Strong Buy rating, seventeen have given a Buy rating and four have given a Hold rating to the stock. According to MarketBeat.com, Danaher has a consensus rating of “Moderate Buy” and a consensus price target of $235.41.

Key Stories Impacting Danaher

Here are the key news stories impacting Danaher this week:

• Positive Sentiment: Danaher and NVIDIA announced an AI collaboration to combine Danaher’s scientific instruments, laboratory workflows, automation technology and software with NVIDIA’s accelerated computing and AI capabilities. The partnership is intended to advance autonomous science and speed drug discovery and other laboratory research. Danaher Collaborates with NVIDIA to Advance Autonomous Science
• Positive Sentiment: Danaher is also preparing to launch its first AI-powered autonomous laboratory, targeted to operate at commercial scale in early 2027. The initiative could support longer-term growth in laboratory automation and strengthen the company’s position in AI-enabled life-science research. How to Invest in AI Drug Discovery
• Positive Sentiment: Multiple Zacks reports say Danaher has a favorable combination of earnings-estimate trends and Earnings ESP, suggesting potential for the company to exceed consensus estimates in its next quarterly report. Danaher has also recently demonstrated earnings momentum, with its latest reported quarter exceeding both EPS and revenue expectations. Will Danaher Beat Estimates Again in Its Next Earnings Report?
• Neutral Sentiment: Danaher is projected to announce earnings on Wednesday. Investors will be watching revenue growth, management’s outlook and whether diagnostics and life-sciences demand support the anticipated improvement in earnings. Danaher Projected to Announce Earnings

Danaher Company Profile

Danaher Corporation (NYSE: DHR) is a global science and technology company that develops and manufactures products, services and solutions for the life sciences, diagnostics and biotechnology industries. Its offerings help researchers, healthcare professionals and biopharmaceutical manufacturers discover, develop, produce and analyze medicines and other biological products.

The company operates through businesses that provide laboratory instruments, consumables, software and services, including technologies for cell analysis, genomics, protein research, bioprocessing and clinical diagnostics.